Top Markets
Coin of the day
Lucira Health, Inc. Lucira Health, Inc.

Lucira Health, Inc.

LHDX
Rang in Aktien #33752
Lucira Health, Inc. is a medical technology enterprise dedicated to the... Lucira Health, Inc. is a medical technology enterprise dedicated to the development and commercialization of diagnostic test kits for infectious diseases. The company has innovated a platform capable of providing molecular testing capabilities. Among its current product offerings is the LUCIRA COVID-19 All-In-One Test Kit, and it is also progressing with the development of diagnostic solutions for influenza A and B viruses. Lucira Health holds a patent license agreement with Eiken Chemical Co., Ltd., alongside technical and manufacturing service agreements with Jabil, Inc. and Jabil MSA, respectively. Founded in 2013, the company operated as DiAssess Inc. until January 2020 when it rebranded to Lucira Health, Inc. Its main offices are situated in Emeryville, California.
Aktienkurs
$0.4523
Zuletzt synchronisiert: 2023-03-03
Marktkapitalisierung
$6.97M
Veränderung (1 Tag)
-19.23%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Lucira Health, Inc. (LHDX)

Kategorie

EPS für Lucira Health, Inc. (LHDX)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Lucira Health, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Lucira Health, Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber